Article Details
Retrieved on: 2025-04-20 17:42:49
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Emerging therapies aim to inhibit the FGFR3 pathway at various levels. These include monoclonal antibodies, decoy receptors like recifercept, FGFR- ...
Article found on: www.news-medical.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here